Lantus and Tamiflu expired in patent on February

On February, Lantus and Tamiflu will expired in patent.

First of all, the Sanofi’s antidiabetic treatments, Lantus Inj Vial, Lantus Inj Solostar and Lantus Inj Cartridge, have been expired in their substance and use patents since the 6^th.

Their PMS expiration data was 5 February 2010, and their 6-year patent duration ended from the 6^th.

On the 26^th, the Roche’s Tamiflu product line, such as ...